Published in Epidemiol Infect on January 12, 2016
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (2000) 8.86
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol (2010) 7.72
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol (1999) 6.25
Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep (2010) 6.25
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
The continuing HIV epidemic among men who have sex with men. Am J Public Health (2001) 5.56
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med (2006) 5.49
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr (1993) 5.08
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med (2003) 3.98
Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet (2003) 3.84
Natural history of HIV infection. AIDS (1989) 3.75
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health (2003) 3.61
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (2001) 3.56
Discordance between sexual behavior and self-reported sexual identity: a population-based survey of New York City men. Ann Intern Med (2006) 3.51
Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep (2007) 3.51
A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. Am J Epidemiol (2008) 3.36
Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A (2007) 3.29
Likelihood-based inference for stochastic models of sexual network formation. Theor Popul Biol (2004) 3.06
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol (2000) 2.95
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet (2006) 2.86
HIV risk, prevention, and testing behaviors among men who have sex with men--National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. MMWR Surveill Summ (2011) 2.84
Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA (2008) 2.77
Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1995) 2.74
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction (2010) 2.65
HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health (2005) 2.62
Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS (2002) 2.57
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav (2008) 2.49
Sexual risk behavior among HIV-positive men who have sex with men: a literature review. Patient Educ Couns (2006) 2.36
The transmission dynamics of human immunodeficiency virus (HIV). Philos Trans R Soc Lond B Biol Sci (1988) 2.35
Modeling sequence evolution in acute HIV-1 infection. J Theor Biol (2009) 2.32
Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2005) 2.32
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol (2003) 2.32
The sexual behavior of US adults: results from a national survey. Am J Public Health (1993) 2.31
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health (2008) 2.23
Degree distributions in sexual networks: a framework for evaluating evidence. Sex Transm Dis (2008) 2.15
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend (1996) 2.13
Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav (2011) 2.12
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics (2006) 2.10
Formalizing the role of agent-based modeling in causal inference and epidemiology. Am J Epidemiol (2014) 2.08
Estimating per-act HIV transmission risk: a systematic review. AIDS (2014) 2.04
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med (2003) 1.91
HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996. Am J Public Health (2000) 1.90
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79
Sex acts, sex partners, and sex budgets: implications for risk factor analysis and estimation of HIV transmission probabilities. J Acquir Immune Defic Syndr (1993) 1.79
HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health (2005) 1.77
Determinants of HAART discontinuation among injection drug users. AIDS Care (2005) 1.74
Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.71
Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS (2006) 1.70
A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr (1992) 1.65
Statistical analysis of HIV infectivity based on partner studies. Biometrics (1990) 1.63
Estimation of HIV prevalence, risk factors, and testing frequency among sexually active men who have sex with men, aged 18-64 years--New York City, 2002. J Urban Health (2007) 1.63
Can syringe exchange serve as a conduit to substance abuse treatment? J Subst Abuse Treat (1998) 1.61
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
Statewide estimation of racial/ethnic populations of men who have sex with men in the U.S. Public Health Rep (2011) 1.58
HIV seroprevalence and risk behaviors among lesbians and bisexual women in San Francisco and Berkeley, California. Am J Public Health (1995) 1.57
Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug Alcohol Depend (2001) 1.55
Men who have sex with men in the United States: demographic and behavioral characteristics and prevalence of HIV and HSV-2 infection: results from National Health and Nutrition Examination Survey 2001-2006. Sex Transm Dis (2010) 1.53
Agent-based modeling of drinking behavior: a preliminary model and potential applications to theory and practice. Am J Public Health (2006) 1.49
Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health (1999) 1.47
Drug abuse treatment success among needle exchange participants. Public Health Rep (1998) 1.45
Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat (2000) 1.45
The natural history of HIV-1 infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr (2004) 1.44
Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001. Arch Intern Med (2004) 1.42
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol (1996) 1.40
Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts. AIDS Res Ther (2007) 1.39
An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men. J Urban Health (2004) 1.38
HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009. MMWR Morb Mortal Wkly Rep (2012) 1.35
Methamphetamine and cocaine users: differences in characteristics and treatment retention. J Psychoactive Drugs (2000) 1.35
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol (2005) 1.34
Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr (1990) 1.33
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (2005) 1.32
Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.31
Sexual partner concurrency among STI clinic patients with a steady partner: correlates and associations with condom use. Sex Transm Infect (2009) 1.26
Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health (2006) 1.25
Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. Stat Med (1989) 1.22
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (1994) 1.20
Dynamic microsimulation models for health outcomes: a review. Med Decis Making (2010) 1.18